Vanda Pharmaceuticals Stock Price History
| VNDA Stock | USD 4.42 0.28 5.96% |
Below is the normalized historical share price chart for Vanda Pharmaceuticals extending back to April 12, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vanda Pharmaceuticals stands at 4.42, as last reported on the 17th of February 2025, with the highest price reaching 4.59 and the lowest price hitting 4.20 during the day.
If you're considering investing in Vanda Stock, it is important to understand the factors that can impact its price. Vanda Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.067, which indicates the firm had a -0.067 % return per unit of risk over the last 3 months. Vanda Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vanda Pharmaceuticals' Coefficient Of Variation of (1,094), variance of 5.56, and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide.
At present, Vanda Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 783 M, whereas Common Stock Total Equity is forecasted to decline to about 39.5 K. . As of February 17, 2025, Price To Sales Ratio is expected to decline to 1.33. In addition to that, Price Earnings Ratio is expected to decline to -15.47. Vanda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of April 2006 | 200 Day MA 4.9234 | 50 Day MA 4.797 | Beta 0.767 |
Vanda |
Sharpe Ratio = -0.067
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VNDA |
Estimated Market Risk
| 2.25 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vanda Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vanda Pharmaceuticals by adding Vanda Pharmaceuticals to a well-diversified portfolio.
Price Book 0.4762 | Enterprise Value Ebitda 12.9072 | Price Sales 1.2966 | Shares Float 52.5 M | Wall Street Target Price 10.43 |
Vanda Pharmaceuticals Stock Price History Chart
There are several ways to analyze Vanda Stock price data. The simplest method is using a basic Vanda candlestick price chart, which shows Vanda Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 27, 2024 | 5.19 |
| Lowest Price | February 3, 2025 | 4.31 |
Vanda Pharmaceuticals February 17, 2025 Stock Price Synopsis
Various analyses of Vanda Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vanda Stock. It can be used to describe the percentage change in the price of Vanda Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vanda Stock.| Vanda Pharmaceuticals Price Action Indicator | (0.12) | |
| Vanda Pharmaceuticals Price Rate Of Daily Change | 0.94 | |
| Vanda Pharmaceuticals Price Daily Balance Of Power | (0.72) |
Vanda Pharmaceuticals February 17, 2025 Stock Price Analysis
Vanda Stock Price History Data
The price series of Vanda Pharmaceuticals for the period between Tue, Nov 19, 2024 and Mon, Feb 17, 2025 has a statistical range of 1.15 with a coefficient of variation of 5.58. The daily prices for the period are distributed with arithmetic mean of 4.75. The median price for the last 90 days is 4.75.| Open | High | Low | Close | Volume | ||
02/17/2025 | 4.70 | 4.59 | 4.20 | 4.42 | ||
02/17/2025 | 4.70 | 4.59 | 4.20 | 4.42 | ||
| 02/14/2025 | 4.58 | 4.59 | 4.20 | 4.42 | 1,978,370 | |
| 02/13/2025 | 4.80 | 4.80 | 4.57 | 4.70 | 958,612 | |
| 02/12/2025 | 4.65 | 4.78 | 4.63 | 4.75 | 315,578 | |
| 02/11/2025 | 4.56 | 4.75 | 4.52 | 4.72 | 428,807 | |
| 02/10/2025 | 4.82 | 4.82 | 4.56 | 4.62 | 503,888 | |
| 02/07/2025 | 4.75 | 4.83 | 4.65 | 4.80 | 934,009 | |
| 02/06/2025 | 4.56 | 4.71 | 4.50 | 4.69 | 590,405 | |
| 02/05/2025 | 4.46 | 4.55 | 4.46 | 4.53 | 491,413 | |
| 02/04/2025 | 4.31 | 4.48 | 4.23 | 4.48 | 395,894 | |
| 02/03/2025 | 4.35 | 4.35 | 4.22 | 4.31 | 570,093 | |
| 01/31/2025 | 4.59 | 4.60 | 4.38 | 4.41 | 508,513 | |
| 01/30/2025 | 4.60 | 4.61 | 4.48 | 4.58 | 378,946 | |
| 01/29/2025 | 4.43 | 4.59 | 4.40 | 4.53 | 497,990 | |
| 01/28/2025 | 4.42 | 4.51 | 4.37 | 4.44 | 554,655 | |
| 01/27/2025 | 4.48 | 4.58 | 4.38 | 4.45 | 589,772 | |
| 01/24/2025 | 4.39 | 4.41 | 4.33 | 4.40 | 632,971 | |
| 01/23/2025 | 4.33 | 4.43 | 4.30 | 4.42 | 491,728 | |
| 01/22/2025 | 4.51 | 4.55 | 4.35 | 4.35 | 2,130,213 | |
| 01/21/2025 | 4.40 | 4.53 | 4.39 | 4.51 | 489,339 | |
| 01/17/2025 | 4.45 | 4.45 | 4.30 | 4.36 | 330,159 | |
| 01/16/2025 | 4.43 | 4.44 | 4.30 | 4.44 | 458,285 | |
| 01/15/2025 | 4.43 | 4.45 | 4.34 | 4.45 | 459,105 | |
| 01/14/2025 | 4.55 | 4.55 | 4.35 | 4.38 | 459,726 | |
| 01/13/2025 | 4.60 | 4.60 | 4.43 | 4.53 | 615,022 | |
| 01/10/2025 | 4.60 | 4.64 | 4.55 | 4.60 | 555,147 | |
| 01/08/2025 | 4.86 | 4.89 | 4.59 | 4.65 | 584,535 | |
| 01/07/2025 | 4.83 | 4.95 | 4.79 | 4.85 | 599,589 | |
| 01/06/2025 | 4.84 | 4.89 | 4.77 | 4.79 | 510,441 | |
| 01/03/2025 | 4.83 | 4.90 | 4.79 | 4.85 | 457,112 | |
| 01/02/2025 | 4.85 | 4.96 | 4.79 | 4.82 | 432,052 | |
| 12/31/2024 | 4.77 | 4.85 | 4.71 | 4.79 | 501,957 | |
| 12/30/2024 | 4.80 | 4.90 | 4.74 | 4.78 | 389,035 | |
| 12/27/2024 | 4.80 | 4.85 | 4.77 | 4.81 | 412,262 | |
| 12/26/2024 | 4.79 | 4.86 | 4.74 | 4.81 | 392,400 | |
| 12/24/2024 | 4.65 | 4.83 | 4.65 | 4.83 | 292,919 | |
| 12/23/2024 | 4.77 | 4.88 | 4.60 | 4.68 | 684,299 | |
| 12/20/2024 | 4.59 | 4.83 | 4.59 | 4.78 | 926,409 | |
| 12/19/2024 | 4.54 | 4.67 | 4.54 | 4.63 | 717,425 | |
| 12/18/2024 | 4.73 | 4.81 | 4.49 | 4.55 | 676,234 | |
| 12/17/2024 | 4.61 | 4.75 | 4.60 | 4.73 | 519,238 | |
| 12/16/2024 | 4.60 | 4.69 | 4.57 | 4.63 | 403,073 | |
| 12/13/2024 | 4.60 | 4.62 | 4.51 | 4.61 | 461,158 | |
| 12/12/2024 | 4.67 | 4.72 | 4.57 | 4.62 | 634,355 | |
| 12/11/2024 | 4.61 | 4.79 | 4.45 | 4.67 | 1,777,009 | |
| 12/10/2024 | 4.83 | 4.84 | 4.55 | 4.60 | 1,710,089 | |
| 12/09/2024 | 4.87 | 4.95 | 4.81 | 4.82 | 616,584 | |
| 12/06/2024 | 4.76 | 4.87 | 4.74 | 4.84 | 659,777 | |
| 12/05/2024 | 4.82 | 4.92 | 4.75 | 4.78 | 538,068 | |
| 12/04/2024 | 4.91 | 4.91 | 4.76 | 4.84 | 760,474 | |
| 12/03/2024 | 5.04 | 5.04 | 4.87 | 4.91 | 670,995 | |
| 12/02/2024 | 5.15 | 5.15 | 5.03 | 5.04 | 310,826 | |
| 11/29/2024 | 5.21 | 5.25 | 5.08 | 5.15 | 264,859 | |
| 11/27/2024 | 5.04 | 5.42 | 5.01 | 5.19 | 833,924 | |
| 11/26/2024 | 5.03 | 5.04 | 4.88 | 4.98 | 529,323 | |
| 11/25/2024 | 5.15 | 5.21 | 5.04 | 5.05 | 487,097 | |
| 11/22/2024 | 4.93 | 5.16 | 4.90 | 5.09 | 587,664 | |
| 11/21/2024 | 4.91 | 4.94 | 4.83 | 4.94 | 344,865 | |
| 11/20/2024 | 4.90 | 4.92 | 4.82 | 4.90 | 396,176 | |
| 11/19/2024 | 4.93 | 4.96 | 4.84 | 4.92 | 434,817 |
About Vanda Pharmaceuticals Stock history
Vanda Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vanda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vanda Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vanda Pharmaceuticals stock prices may prove useful in developing a viable investing in Vanda Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.8 M | 48.2 M | |
| Net Income Applicable To Common Shares | 7.2 M | 8.4 M |
Vanda Pharmaceuticals Quarterly Net Working Capital |
|
Vanda Pharmaceuticals Stock Technical Analysis
Vanda Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Vanda Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vanda Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vanda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vanda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.84) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |